Hematocrit as disability predictor 30 days post-ischemia stroke

Abstract

Objective. Measure whether the hematocrit can be the disability predictor in 30 days post ischemic stroke. Methods. This study is a cohort retrospective using secondary data from medical records of patients with stroke ischemia. The total sample in this study is 54, consisting of group with hematocrit <43% and group with hematocrit >43.5%. Disability is measured with modified Rankin Scale (mRS) which consist of independent group (score 0-2) and dependent group (score 3-5); and Barthel Index score which consist of independent group (score >12) and dependent group (score <12) using Mann Whitney test. Results. The mean age of the population was 60.333+10.97338 which the most age group that suffering from stroke is late elderly (56-65 years old). Majority of subjects is men (70.37%). The mean of hematocrit value 42.62+3.550467%, there are 34 subjects (62.96%) in group with hematocrit <43.5% and 20 subjects (37.04%) in group with hematocrit >43.5%. There are no significant associations between hematocrit and mRS (p-value = 0.735) also BI (p-value = 0.49), but there are significant associations between age (p value = 0.043) and sex (p-value = 0.002). Conclusion. Hematocrit value cannot be used as a predictor of disability 30 days post ischemic stroke.